ConductScience.org, home

Paper39019010

Development of a hydrogen peroxide-inactivated vaccine that protects against viscerotropic yellow fever in a non-human primate model.

Amanna IJ and 14 others. Cell Rep Med, 2024. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Development of a hydrogen peroxide-inactivated vaccine that protects against viscerotropic yellow fever in a non-human primate model. Papers, record 39019010. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39019010

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Development of a hydrogen peroxide-inactivated vaccine that protects against viscerotropic yellow fever in a non-human primate model.
PubMed
Journal
Cell Rep Med
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
1.36, provisional
iCite
Revised in PubMed
2024-09-23
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Amanna IJIan J
2Thomas AArchana
3Engelmann FFlora
4Hammarlund EErika
5Raué HPHans-Peter
6Bailey ALAdam L
7Poore EAElizabeth A
8Quintel BKBenjamin K
9Lewis ADAnne D
10Axthelm MKMichael K
11Johnson ALAmanda L
12Colgin LMALois M A
13Diamond MSMichael S
14Messaoudi IIlhem
15Slifka MKMark K

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hydrogen PeroxideMajor topic
Macaca mulattaMajor topic
Vaccines, InactivatedMajor topic
Yellow Fever VaccineMajor topic
Yellow FeverMajor topic
Yellow fever virusMajor topic
Antibodies, NeutralizingMajor topic
Antibodies, ViralMajor topic
Disease Models, AnimalMajor topic
Animals
Vaccines, Attenuated
Chlorocebus aethiops
Vero Cells
Humans

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AI073755NIAID NIH HHSUnited StatesR01AI073755PubMed and NIHNIH RePORTER
DP5 OD029608NIH HHSUnited StatesDP5OD029608PubMed and NIHNIH RePORTER
R44 AI079898NIAID NIH HHSUnited StatesR44AI079898PubMed and NIHNIH RePORTER
P51 OD011092NIH HHSUnited StatesP51OD011092PubMed and NIHNIH RePORTER
U54 AI081680NIAID NIH HHSUnited StatesU54AI081680PubMed and NIHNIH RePORTER

Download CSV of grants

References88

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110632996Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA.Trop Med Int Health1999https://conductscience.org/library/papers/10632996PubMed
218398296Protective immunity following vaccination: how is it defined?Hum Vaccin2008https://conductscience.org/library/papers/18398296PubMed
322635006Development of a new hydrogen peroxide–based vaccine platform.Nat Med2012https://conductscience.org/library/papers/22635006PubMed
434577591The Present and Future of Yellow Fever Vaccines.Pharmaceuticals (Basel)2021https://conductscience.org/library/papers/34577591PubMed
524800812Yellow Fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data.PLoS Med2014https://conductscience.org/library/papers/24800812PubMed
64984200Yellow fever virus. II. Factors affecting the plaque neutralization test.Appl Microbiol1969https://conductscience.org/library/papers/4984200PubMed
723028428A flow cytometry-based assay for quantifying non-plaque forming strains of yellow fever virus.PLoS One2012https://conductscience.org/library/papers/23028428PubMed
835788221Development of a next-generation chikungunya virus vaccine based on the HydroVax platform.PLoS Pathog2022https://conductscience.org/library/papers/35788221PubMed
917012873
Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes.
Hum Vaccin2006https://conductscience.org/library/papers/17012873PubMed
1028017559Spread of yellow fever virus outbreak in Angola and the Democratic Republic of the Congo 2015-16: a modelling study.Lancet Infect Dis2017https://conductscience.org/library/papers/28017559PubMed
1117316927Neurological adverse events temporally associated to mass vaccination against yellow fever in Juiz de Fora, Brazil, 1999-2005.Vaccine2007https://conductscience.org/library/papers/17316927PubMed
1211803060Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections.Vaccine2002https://conductscience.org/library/papers/11803060PubMed
137235133Pathophysiologic correlations in a rhesus monkey model of yellow fever with special observations on the acute necrosis of B cell areas of lymphoid tissues.Am J Trop Med Hyg1981https://conductscience.org/library/papers/7235133PubMed
143944585Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses.J Gen Virol1986https://conductscience.org/library/papers/3944585PubMed
1527919629Pre-clinical development of a hydrogen peroxide-inactivated West Nile virus vaccine.Vaccine2017https://conductscience.org/library/papers/27919629PubMed
1616908625Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis.J Exp Med2006https://conductscience.org/library/papers/16908625PubMed
1713923245Eczema vaccinatum treated with n-methylisatin beta-thiosemicarbazone.Br Med J1962https://conductscience.org/library/papers/13923245PubMed
1833268494Consumptive coagulopathy of severe yellow fever occurs independently of hepatocellular tropism and massive hepatic injury.Proc Natl Acad Sci U S A2020https://conductscience.org/library/papers/33268494PubMed
1925862300An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures.Vaccine2015https://conductscience.org/library/papers/25862300PubMed
2030346562Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among US travellers.J Travel Med2018https://conductscience.org/library/papers/30346562PubMed

See all 88 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
41600981The Yellow Fever Vaccine Journey: Milestones and Future Directions.Vaccines (Basel)2026https://conductscience.org/library/papers/41600981PubMed
41032627An inactivated trivalent virion-based vaccine protects against aerosol challenge with encephalitic alphaviruses in mice and macaques.Sci Transl Med2025https://conductscience.org/library/papers/41032627PubMed
40904452Molecular ingredients of an immunogen for long-lasting IgG.Front Immunol2025https://conductscience.org/library/papers/40904452PubMed
40662744Lessons learned from successful implementation of tetanus and diphtheria vaccination programs.Clin Microbiol Rev2025https://conductscience.org/library/papers/40662744PubMed
40364846A bivalent self-amplifying RNA vaccine against yellow fever and Zika viruses.Front Immunol2025https://conductscience.org/library/papers/40364846PubMed
40284841Yellow Fever in Non-Human Primates: A Veterinary Guide from a One Health Perspective.Vet Sci2025https://conductscience.org/library/papers/40284841PubMed
39772058An Inactivated West Nile Virus Vaccine Candidate Based on the Lineage 2 Strain.Vaccines (Basel)2024https://conductscience.org/library/papers/39772058PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39019010

GET https://conductscience.org/api/papers/v1/39019010/references?page=2